GJA1 and glioblastoma: Interestingly, by knocking out endogenous Cx43 gene expression in glioblastoma cells using CRISPR/Cas9‐mediated genome editing, we observed similar responses in Cx43‐knockout cells treated with TMZ alone as in WT cells treated with TO and TMZ combined.